0.06
0.06 (0%)
As of Feb 12, 2025
Biofrontera Inc. [BFRIW]
Source:
Company Overview
Biofrontera Inc. is a United States based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment ofdermatological conditions with a focus on photodynamic therapy (“PDT”).
| Country | United States |
| Headquarters | woburn, massachusetts |
| Phone Number | (781) 245-1325 |
| Industry | manufacturing |
| CEO | Hermann Lã¼Bbert |
| Website | https://www.skincancer.org |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $37.3 |
| Operating Profit | $-17.2 |
| Net Income | $-17.8 |
| Net Cash | $4.6 |
Profit Ratios
| Gross Margin | $37.3 |
| Operating Margin | -46.1 |
| Profit as % of Revenues | -210.2% |
| Profit as % of Assets | -71% |
| Profit as % of Stockholder Equity | -400.6% |
Management Effectiveness
| Return on Equity | -400.6% |
| Return on Assets | -80.4% |
| Turnover Ratio | 149.2% |
| EBITA | $-17.2 |
Balance Sheet and Cash Flow Measures
| Total Assets | $22.1 |
| Total Liabilities | $17.7 |
| Operating Cash Flow | $-10.3 |
| Investing Cash Flow | $-0 |
| Financing Cash Flow | $14.8 |
